Sensei Biotherapeutics, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, Loss from operations was $7,969,000 against $4,103,000 a year ago. Net loss was $7,972,000 against $4,692,000 a year ago. Net loss per share, basic and diluted was $0.42 against $4.00 a year ago.